Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

21.36 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q4
Revenue 0010.3120000000000000000000000000000000000000000
Cost of Revenue 2.3392.2545.1561.7611.7221.6731.7781.6351.5661.3023.1850.80.70.67400000000000000000000000000000
Gross Profit -2.339-2.2545.156-1.761-1.722-1.673-1.778-1.635-1.566-1.302-3.185-0.8-0.7-0.67400000000000000000000000000000
Gross Profit Ratio 000.50000000000000000000000000000000000000000
Reseach & Development Expenses 44.79243.7641.74446.84451.38346.37150.03743.38341.35630.79432.16139.97524.79828.54251.03721.65716.73116.95714.66814.82913.98915.13723.6813.06510.7725.7430.6542.8183.6247.0979.4938.4126.4657.6155.9193.6121.9541.0690.9371.2431.8621.551.592
General & Administrative Expenses 27.36722.14821.53518.58517.37415.82319.04515.10512.85411.7712.1719.6719.2510.688.2015.736.8287.1634.9814.3364.4033.8082.8652.2684.18.6623.5483.8952.2322.8692.7462.3112.3152.5222.3091.8251.7281.980.7750.8430.3320.1620.082
Selling & Marketing Expenses -0.786-0.78700000000000000000000000000000000000000000
SG&A 26.58121.36121.53518.58517.37415.82319.04515.10512.85411.7712.1719.6719.2510.688.2015.736.8287.1634.9814.3364.4033.8082.8652.2684.18.6623.5483.8952.2322.8692.7462.3112.3152.5222.3091.8251.7281.980.7750.8430.3320.1620.082
Other Expenses 000000-0.5000-0.5000.500000000.250.028-0.039-0.0050.015000.1920.1920000000000000.001
Operating Expenses 71.37365.12163.27965.42968.75762.19468.58258.48854.2142.56443.83249.64634.04838.72259.23827.38723.55924.1219.64919.16518.39218.69526.54515.33314.87214.2194.2026.7135.8569.96612.23910.7238.7810.1378.2285.4373.6823.0491.7122.0862.1941.7121.674
Operating Income -73.712-67.375-63.279-65.429-68.757-62.194-69.082-58.488-54.21-42.564-44.332-49.646-34.048-39.222-59.238-27.387-23.559-24.12-19.649-19.165-18.392-18.945-26.545-15.333-14.872-14.405-4.202-6.713-5.856-9.966-12.239-10.723-8.78-10.137-8.228-5.437-3.682-3.049-1.712-2.086-2.194-1.712-1.674
Operating Income Ratio 00-6.1360000000000000000000000000000000000000000
Total Other Income Expenses Net 4.0665.3213.6193.533.0563.8592.3590.732-0.192-0.418-1.264-0.472-0.7270.5-1.678-1.693-0.1240.0620.2450.3680.2560.2470.829-0.039-0.0050.015-0.668-0.682-0.706-0.704-0.735-0.4050.0960.0690.056-50.3651.8592.061-0.191-0.058-0.405-0.193-0.051
Income Before Tax -69.646-62.054-59.66-61.899-65.701-58.335-66.723-57.756-54.402-42.982-44.247-50.118-34.525-40.179-60.916-29.08-25.04-24.664-19.855-19.284-18.68-19.451-27.319-16.089-15.767-15.343-4.87-7.395-6.562-10.67-12.974-11.128-8.684-10.068-8.172-55.961-2.387-1.462-2.148-2.388-2.847-2.148-1.971
Income Before Tax Ratio 00-5.7850000000000000000000000000000000000000000
Income Tax Expense 001.626-1.7593.524-3.391-2.358-0.7320.1920.4181.2640.8060.2512.2290.2370.5181.7861.5731.3431.4661.6321.6042.0571.1371.3581.4420.2450.2190.1830.1720.1580.120.0960.0690.0560.1920.563000000.246
Net Income -69.646-62.054-59.66-61.899-65.701-54.944-64.365-57.024-54.594-43.4-44.247-50.118-34.525-40.179-60.916-29.08-25.04-24.664-19.855-19.284-18.68-19.451-27.319-16.089-15.767-15.343-4.87-7.395-6.562-10.67-12.974-11.128-8.684-10.068-8.172-55.961-2.387-1.462-2.148-2.388-2.847-2.148-1.971
Net Income Ratio 00-5.7850000000000000000000000000000000000000000
EPS -0.74-0.66-0.64-0.75-0.82-0.69-0.88-0.86-0.83-0.67-0.69-0.79-0.55-0.65-1.1-0.53-0.45-0.45-0.36-0.38-0.38-0.43-0.61-0.4-0.4-0.42-0.13-1.09-0.97-1.57-1.92-1.65-1.3-1.52-1.24-9.92-0.58-0.76-1.02-1.14-1.35-1.02-0.94
EPS Diluted -0.74-0.66-0.64-0.75-0.82-0.69-0.88-0.86-0.83-0.67-0.69-0.79-0.55-0.65-1.1-0.53-0.45-0.45-0.36-0.38-0.38-0.43-0.61-0.4-0.4-0.42-0.13-1.09-0.97-1.57-1.92-1.65-1.3-1.52-1.24-9.92-0.58-0.76-1.02-1.14-1.35-1.02-0.94
EBITDA -71.373-65.121-57.255-65.429-63.502-56.194-63.954-56.05-53.541-40.639-42.983-48.032-32.841-37.776-58.371-26.596-23.006-23.035-18.656-18.065-17.392-17.802-25.994-14.837-14.33-13.833-3.919-6.456-5.61-9.733-12.023-10.564-8.649-10.031-8.134-5.398-3.682-3.049-1.712-2.086-2.194-1.712-1.673
EBITDA Ratio 00-5.5520000000000000000000000000000000000000000